Experimental cancer vaccine extends survival in brain cancer trial but falls short of statistical significance
The randomized, double-blind, placebo-controlled trial included 233 evaluable patients across 11 US cancer centers
Indianpharmapost has shared only the headline of this report so far. The full story, with all its details, is on Indianpharmapost’s own website.
Read the full report on Indianpharmapost
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Indianpharmapost
- Published
- Sunday, 11 October 2026, 12:00 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Indianpharmapost with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
